Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for banking industry professionals · Friday, March 29, 2024 · 699,697,636 Articles · 3+ Million Readers

Skanska builds ambulatory care cancer center in Livingston, New Jersey, USA, for USD 58M, about SEK 570M

STOCKHOLM, Sept. 30, 2022 /PRNewswire/ -- Skanska has signed a contract with RWJBarnabas Health to build an ambulatory care cancer center in Livingston, New Jersey, USA. The contract is worth USD 58M, about SEK 570M, which will be included in the US order bookings for the third quarter 2022.

The five-story building on the Cooperman Barnabas Medical Center campus, totaling 13,000 gross square meters, is designed to support patients' care and wellbeing. The new facility will provide outpatient cancer treatment, including four new linear accelerators and a high-dose MRI unit. A parking garage will also be constructed.

Construction started September 2022, and completion is scheduled for July 2025.

For further information please contact:

Mia Walton, VP Communications, Skanska USA Building, tel + 1 (240) 672 17 89
Jacob Birkeland, Head of Media Relations and Public Affairs, Skanska AB, tel: +46 (0)10 449 19 57
Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skanska/r/skanska-builds-ambulatory-care-cancer-center-in-livingston--new-jersey--usa--for-usd-58m--about-sek-,c3639349

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/skanska-builds-ambulatory-care-cancer-center-in-livingston-new-jersey-usa-for-usd-58m-about-sek-570m-301637528.html

SOURCE Skanska

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release